219
Views
15
CrossRef citations to date
0
Altmetric
Letrozole

Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin

, , , , &
Pages 209-215 | Received 14 Oct 2009, Accepted 19 Apr 2010, Published online: 08 Jun 2010

References

  • Simpson ER, Mahendroo MS, Nichols JE, Bulun SE. Aromatase gene expression in adipose tissue: relationship to breast cancer. Int J Fertil Menopausal Stud 1994;39(Suppl 2):75–83.
  • Zapata E, Zubiaurre L, Bujanda L, Pierola A. Anastrozole-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2006;18:1233–1234.
  • Femara®. Letrozole tablets, Vol. 1. East Hanover: Novartis Pharmaceuticals; 2001.
  • Green PS, Gordon K, Simpkins JW. Phenolic a ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 1997;63:229–235.
  • Naftolin F, Perez J, Leranth CS, Redmond DE, Jr., Garcia-Segura LM. African green monkeys have sexually dimorphic and estrogen-sensitive hypothalamic neuronal membranes. Brain Res Bull 1990;25:575–579.
  • Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J. Protective effect of estradiol on hepatocytic oxidative damage. World J Gastroenterol 2002;8:363–366.
  • Reiter RJ, Korkmaz A, Paredes SD, Manchester LC, Tan DX. Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides. Neuro Endocrinol Lett 2008;29:609–613.
  • Calvo JR, Reiter RJ, Garcia JJ, Ortiz GG, Tan DX, Karbownik M. Characterization of the protective effects of melatonin and related indoles against α-naphthylisothiocyanate-induced liver injury in rats. J Cell Biochem 2001;80:461–470.
  • Suzme R, Gurdol F, Deniz G, Ozden T: et al Response in DNA ploidy of hepatocytes to tamoxifen and/or melatonin in vivo.Res Commun Mol Pathol Pharmacol 2001;109:275–286.
  • Karbownik M, Reiter RJ, Cabrera J, Garcia JJ. Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage. Mutat Res 2001;474:87–92.
  • Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan DX, Lewinski A. Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention. Exp Biol Med (Maywood) 2001;226:707–712.
  • Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407–421.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497–500.
  • Aebi H. Methods of enzymatic analysis. In: Bergmeyer U, editor. New York: Academic Press; 1984.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275.
  • Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable abts radical cation. Clin Biochem 2004;37:277–285.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111.
  • Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 2005;100:61–64.
  • Pannen BH. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 2002;94:1448–1457.
  • Nakatani T, Inouye M, Mirochnitchenko O. Overexpression of antioxidant enzymes in transgenic mice decreases cellular ploidy during liver regeneration. Exp Cell Res 1997;236:137–146.
  • Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 2005;11:1031–1047.
  • Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003;93:170–177.
  • Tschugguel W, Stonek F, Zhegu Z, Dietrich W, Schneeberger C, Stimpfl T, Waldhoer T, Vycudilik W, Huber JC. Estrogen increases endothelial carbon monoxide, heme oxygenase 2, and carbon monoxide-derived cgmp by a receptor-mediated system. J Clin Endocrinol Metab 2001;86:3833–3839.
  • Lee SY, Andoh T, Murphy DL, Chiueh CC. 17 β-estradiol activates ici 182,780-sensitive estrogen receptors and cyclic gmp-dependent thioredoxin expression for neuroprotection. Faseb J 2003;17:947–948.
  • Montano MM, Deng H, Liu M, Sun X, Singal R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 2004;23:2442–2453.
  • Kiray M, Uysal N, Sonmez A, Acikgoz O, Gonenc S. Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Neurosci Lett 2004;354:225–228.
  • Lund SA, Murdoch J, Van Kirk EA, Murdoch WJ. Mitogenic and antioxidant mechanisms of estradiol action in preovulatory ovine follicles: relevance to luteal function. Biol Reprod 1999;61:388–392.
  • Tabassum H, Parvez S, Rehman H, Banerjee BD, Raisuddin S. Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-induced protein oxidation and lipid peroxidation. J Biochem Mol Toxicol 2007;21:110–117.
  • Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P. Augmented antioxidant status in tamoxifen treated postmenopausal women with breast cancer on co-administration with coenzyme q10, niacin and riboflavin. Cancer Chemother Pharmacol 2008;61:933–941.
  • Tabassum H, Parvez S, Rehman H, Dev Banerjee B, Siemen D, Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum Exp Toxicol 2007;26:509–518.
  • Bhatnagar AS. The discovery and mechanism of action of letrozole. Breast Cancer Res Treat 2007;105(Suppl 1):7–17.
  • Perez EA, Weilbaecher K. Aromatase inhibitors and bone loss. Oncology (Williston Park) 2006;20:1029–1039; discussion 1039–1040,1042,1048.
  • Kannel WB, Wilson PW. Comparison of risk profiles for cardiovascular events: implications for prevention. In: Schrier RW BJ, Ozau VJ, Fauci AS, Abboud FM, editors. Advances in internal medicine. St. Louis: Mosby-Year Book; 1997. 43, pp 39–66.
  • Wojtacki J, Kruszewski WJ, Lesńiewski-Kmak K, Śliwińska M, Czyzewska K, Kruszewska E. Shortterm effects of anastrozole therapy on serum lipid profile in patients with breast cancer, previously treated with tamoxifen. Preliminary report. Nowotwory 2001;51:43–47.
  • Elisaf MS, Bairaktari ET, Nicolaides C, Kakaidi B, Tzallas CS, Katsaraki A, Pavlidis NA. Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer 2001;37:1510–1513.
  • Wasan KM, Goss PE, Pritchard PH, Shepherd L, Palmer MJ, Liu S, Tu D, Ingle JN, Heath M, Deangelis D, et al The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (ncic ctg ma.17l). Ann Oncol 2005;16:707–715.
  • Kim SH, Lee SM. Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/ reperfusion injury in rat liver. J Pineal Res 2008;44:165–171.
  • Sulaiman AA, Al-Shawi NN, Jwaied AH, Mahmood DM, Hussain SA. Protective effect of melatonin against chlorpromazine-induced liver disease in rats. Saudi Med J 2006;27:1477–1482.
  • Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, et al Phase iii study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group. J Clin Oncol 2003;21:2101–2109.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.